NO304428B1 - AnalogifremgangsmÕte for fremstilling av terapeutisk aktive vinylazoler - Google Patents

AnalogifremgangsmÕte for fremstilling av terapeutisk aktive vinylazoler

Info

Publication number
NO304428B1
NO304428B1 NO932044A NO932044A NO304428B1 NO 304428 B1 NO304428 B1 NO 304428B1 NO 932044 A NO932044 A NO 932044A NO 932044 A NO932044 A NO 932044A NO 304428 B1 NO304428 B1 NO 304428B1
Authority
NO
Norway
Prior art keywords
vinylazoles
preparation
therapeutically active
analogous procedure
analogous
Prior art date
Application number
NO932044A
Other languages
English (en)
Norwegian (no)
Other versions
NO932044L (no
NO932044D0 (no
Inventor
Peter Strehlke
Rolf Bohlmann
Martin Schneider
Yukishige Nishino
Hans-Peter Muhn-Seipoldy
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO932044L publication Critical patent/NO932044L/no
Publication of NO932044D0 publication Critical patent/NO932044D0/no
Publication of NO304428B1 publication Critical patent/NO304428B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/61Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms not forming part of a nitro radical, attached to ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO932044A 1990-12-07 1993-06-04 AnalogifremgangsmÕte for fremstilling av terapeutisk aktive vinylazoler NO304428B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4039559A DE4039559A1 (de) 1990-12-07 1990-12-07 Funktionalisierte vinylazole, verfahren zu deren herstellung, pharmazeutische praeparate die diese vinylazole enthalten sowie deren verwendung zur herstellung von arzneimitteln
PCT/EP1991/002359 WO1992010482A1 (de) 1990-12-07 1991-12-09 Funktionalisierte vinylazole enthaltende pharmazeutische präparate, verwendung dieser vinylazole zur herstellung von arzneimitteln, vinylazole selbst sowie verfahren zu deren herstellung

Publications (3)

Publication Number Publication Date
NO932044L NO932044L (no) 1993-06-04
NO932044D0 NO932044D0 (no) 1993-06-04
NO304428B1 true NO304428B1 (no) 1998-12-14

Family

ID=6420083

Family Applications (1)

Application Number Title Priority Date Filing Date
NO932044A NO304428B1 (no) 1990-12-07 1993-06-04 AnalogifremgangsmÕte for fremstilling av terapeutisk aktive vinylazoler

Country Status (17)

Country Link
US (1) US5344834A (pt)
EP (1) EP0550697A1 (pt)
JP (1) JPH06503818A (pt)
KR (1) KR930703263A (pt)
CN (1) CN1064863A (pt)
AU (1) AU660296B2 (pt)
CA (1) CA2097824C (pt)
CS (1) CS369691A3 (pt)
DE (1) DE4039559A1 (pt)
FI (1) FI932572A0 (pt)
HU (1) HUT64036A (pt)
IE (1) IE914259A1 (pt)
IL (1) IL100274A (pt)
NO (1) NO304428B1 (pt)
PT (1) PT99714B (pt)
WO (1) WO1992010482A1 (pt)
ZA (1) ZA919662B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5418250A (en) * 1989-06-14 1995-05-23 Smithkline Beecham Corporation Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists
GB2273704B (en) * 1992-12-16 1997-01-22 Orion Yhtymae Oy Triazolyl diaryl selective aromatase inhibiting compounds
US5395847A (en) * 1993-12-02 1995-03-07 Smithkline Beecham Corporation Imidazolyl-alkenoic acids
EP0943333A1 (de) * 1998-03-18 1999-09-22 S.W. Patentverwertungs GmbH Medikament zur Prophylaxe und/oder Behandlung des Mammakarzinoms enthaltend einen Hemmer der Bildung von Oestrogenen
US20020086856A1 (en) 1998-03-18 2002-07-04 Alfred Schmidt Medicament for preventing and/or treating a mammary carcinoma, containing a steroidal aromatase inhibitor
CN100358866C (zh) * 2004-04-08 2008-01-02 上海交通大学 含对强碱不稳定取代基的n-乙烯基取代吡咯的制备方法
JP6470984B2 (ja) * 2015-01-27 2019-02-13 学校法人東日本学園 アロマターゼ阻害剤及びこれを含む医薬
CN105732977B (zh) * 2016-01-30 2018-03-02 宝鸡文理学院 一种可溶性聚苯并二噻唑‑酰胺荧光聚合物及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1580535A (en) * 1976-08-27 1980-12-03 Ici Ltd Substituted ketones and their use as herbicides
EP0003884A3 (en) * 1978-02-23 1979-09-19 Imperial Chemical Industries Plc Alpha-beta unsaturated ketone derivatives useful as herbicides
DE2826760A1 (de) * 1978-06-19 1980-01-03 Hoechst Ag Derivate des 1,2,4-triazols
JPS62149666A (ja) * 1985-12-25 1987-07-03 Shionogi & Co Ltd N−ビニルアゾ−ル類
US4749713A (en) * 1986-03-07 1988-06-07 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
GB8716650D0 (en) * 1987-07-15 1987-08-19 Ici Plc Use of olefinic compounds

Also Published As

Publication number Publication date
IL100274A0 (en) 1992-09-06
AU660296B2 (en) 1995-06-22
HUT64036A (en) 1993-11-29
ZA919662B (en) 1992-09-30
AU9045491A (en) 1992-07-08
HU9301657D0 (en) 1993-09-28
JPH06503818A (ja) 1994-04-28
NO932044L (no) 1993-06-04
PT99714B (pt) 1999-05-31
NO932044D0 (no) 1993-06-04
FI932572A (fi) 1993-06-04
IL100274A (en) 1996-08-04
CN1064863A (zh) 1992-09-30
DE4039559A1 (de) 1992-06-11
CS369691A3 (en) 1992-06-17
FI932572A0 (fi) 1993-06-04
US5344834A (en) 1994-09-06
WO1992010482A1 (de) 1992-06-25
KR930703263A (ko) 1993-11-29
PT99714A (pt) 1992-10-30
CA2097824A1 (en) 1992-06-08
IE914259A1 (en) 1992-06-17
CA2097824C (en) 2003-04-08
EP0550697A1 (de) 1993-07-14

Similar Documents

Publication Publication Date Title
NO179584C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-acylaminotiazoler
NO179448C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive forbindelser
NO914667D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylderivater
NO914825D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme alfa-oxoacetamider
NO179283C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive substituerte azoler
NO176796C (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive triazolderivater
NO180586C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive substituerte imidazoler
NO914036D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater
NO175978C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive bis-aza-bicykliske forbindelser
NO894842L (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazoler.
NO178619C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive di-t-butylfenoler
NO900032L (no) Fremgangsmaate for fremstilling av terapeutisk aktive tiazol-forbindelser.
NO176275C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive pyridazinonderivater
NO175528C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive fenylacetamid-derivater
NO903941D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive diazepinon-derivater.
NO175714C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive, aromatiske estere
NO173784C (no) Anaslogifremgangsmaate for fremstilling av terapeutisk aktive tieno-tri-azolo-diazepinderivater
NO912797L (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme karbostirilderivater.
NO174203C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive
NO174774C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive benzodiazepiner
NO914071D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser
NO304428B1 (no) AnalogifremgangsmÕte for fremstilling av terapeutisk aktive vinylazoler
NO173606C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tieno- triazolo-diazepin-derivater
NO894949D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme benzopyranylpyrrolinonderivater.
NO904800D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive karbamater.